122 related articles for article (PubMed ID: 35944750)
1. CD146 interaction with integrin β1 activates LATS1-YAP signaling and induces radiation-resistance in breast cancer cells.
Liang Y; Zhou X; Xie Q; Sun H; Huang K; Chen H; Wang W; Zhou B; Wei X; Zeng D; Lin H
Cancer Lett; 2022 Oct; 546():215856. PubMed ID: 35944750
[TBL] [Abstract][Full Text] [Related]
2. Quantitative proteomics reveals ER-α involvement in CD146-induced epithelial-mesenchymal transition in breast cancer cells.
Zeng Q; Zhang P; Wu Z; Xue P; Lu D; Ye Z; Zhang X; Huang Z; Feng J; Song L; Yang D; Jiang T; Yan X
J Proteomics; 2014 May; 103():153-69. PubMed ID: 24704855
[TBL] [Abstract][Full Text] [Related]
3. Integrin α2β1 inhibits MST1 kinase phosphorylation and activates Yes-associated protein oncogenic signaling in hepatocellular carcinoma.
Wong KF; Liu AM; Hong W; Xu Z; Luk JM
Oncotarget; 2016 Nov; 7(47):77683-77695. PubMed ID: 27765911
[TBL] [Abstract][Full Text] [Related]
4. CD146 increases stemness and aggressiveness in glioblastoma and activates YAP signaling.
Liang Y; Voshart D; Paridaen JTML; Oosterhof N; Liang D; Thiruvalluvan A; Zuhorn IS; den Dunnen WFA; Zhang G; Lin H; Barazzuol L; Kruyt FAE
Cell Mol Life Sci; 2022 Jul; 79(8):398. PubMed ID: 35790583
[TBL] [Abstract][Full Text] [Related]
5. CD146, an epithelial-mesenchymal transition inducer, is associated with triple-negative breast cancer.
Zeng Q; Li W; Lu D; Wu Z; Duan H; Luo Y; Feng J; Yang D; Fu L; Yan X
Proc Natl Acad Sci U S A; 2012 Jan; 109(4):1127-32. PubMed ID: 22210108
[TBL] [Abstract][Full Text] [Related]
6. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells.
Yuan J; Liu M; Yang L; Tu G; Zhu Q; Chen M; Cheng H; Luo H; Fu W; Li Z; Yang G
Breast Cancer Res; 2015 May; 17(1):69. PubMed ID: 25990368
[TBL] [Abstract][Full Text] [Related]
7. Soluble CD146 as a Potential Target for Preventing Triple Negative Breast Cancer MDA-MB-231 Cell Growth and Dissemination.
Sharma A; Joshkon A; Ladjimi A; Traboulsi W; Bachelier R; Robert S; Foucault-Bertaud A; Leroyer AS; Bardin N; Somasundaram I; Blot-Chabaud M
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055160
[No Abstract] [Full Text] [Related]
8. β1 integrin-dependent Rac/group I PAK signaling mediates YAP activation of Yes-associated protein 1 (YAP1) via NF2/merlin.
Sabra H; Brunner M; Mandati V; Wehrle-Haller B; Lallemand D; Ribba AS; Chevalier G; Guardiola P; Block MR; Bouvard D
J Biol Chem; 2017 Nov; 292(47):19179-19197. PubMed ID: 28972170
[TBL] [Abstract][Full Text] [Related]
9. FOXM1 transcriptionally regulates expression of integrin β1 in triple-negative breast cancer.
Hamurcu Z; Kahraman N; Ashour A; Ozpolat B
Breast Cancer Res Treat; 2017 Jun; 163(3):485-493. PubMed ID: 28361350
[TBL] [Abstract][Full Text] [Related]
10. β1-Integrin Impacts Rad51 Stability and DNA Double-Strand Break Repair by Homologous Recombination.
Ahmed KM; Pandita RK; Singh DK; Hunt CR; Pandita TK
Mol Cell Biol; 2018 May; 38(9):. PubMed ID: 29463647
[TBL] [Abstract][Full Text] [Related]
11. NF-κB regulates radioresistance mediated by β1-integrin in three-dimensional culture of breast cancer cells.
Ahmed KM; Zhang H; Park CC
Cancer Res; 2013 Jun; 73(12):3737-48. PubMed ID: 23576567
[TBL] [Abstract][Full Text] [Related]
12. GPER/Hippo-YAP signal is involved in Bisphenol S induced migration of triple negative breast cancer (TNBC) cells.
Deng Q; Jiang G; Wu Y; Li J; Liang W; Chen L; Su Q; Li W; Du J; Wong CKC; Chen Z; Wang H
J Hazard Mater; 2018 Aug; 355():1-9. PubMed ID: 29758456
[TBL] [Abstract][Full Text] [Related]
13. Dual inhibition of Wnt and Yes-associated protein signaling retards the growth of triple-negative breast cancer in both mesenchymal and epithelial states.
Sulaiman A; McGarry S; Li L; Jia D; Ooi S; Addison C; Dimitroulakos J; Arnaout A; Nessim C; Yao Z; Ji G; Song H; Gadde S; Li X; Wang L
Mol Oncol; 2018 Apr; 12(4):423-440. PubMed ID: 29316250
[TBL] [Abstract][Full Text] [Related]
14. Binding of galectin-1 to integrin β1 potentiates drug resistance by promoting survivin expression in breast cancer cells.
Nam K; Son SH; Oh S; Jeon D; Kim H; Noh DY; Kim S; Shin I
Oncotarget; 2017 May; 8(22):35804-35823. PubMed ID: 28415760
[TBL] [Abstract][Full Text] [Related]
15. 3,4-Methylenedioxy-β-nitrostyrene inhibits adhesion and migration of human triple-negative breast cancer cells by suppressing β1 integrin function and surface protein disulfide isomerase.
Chen IH; Chang FR; Wu YC; Kung PH; Wu CC
Biochimie; 2015 Mar; 110():81-92. PubMed ID: 25593085
[TBL] [Abstract][Full Text] [Related]
16. Identification of CHD4-β1 integrin axis as a prognostic marker in triple-negative breast cancer using next-generation sequencing and bioinformatics.
Ou-Yang F; Pan MR; Chang SJ; Wu CC; Fang SY; Li CL; Hou MF; Luo CW
Life Sci; 2019 Dec; 238():116963. PubMed ID: 31639396
[TBL] [Abstract][Full Text] [Related]
17. HMGA2 promotes breast cancer metastasis by modulating Hippo-YAP signaling pathway.
Xu J; Fang X; Long L; Wang S; Qian S; Lyu J
Cancer Biol Ther; 2021 Jan; 22(1):5-11. PubMed ID: 33307962
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of the Hippo pathway transcriptional coactivators YAP/TAZ and β1-integrin in conventional osteosarcoma.
Bouvier C; Macagno N; Nguyen Q; Loundou A; Jiguet-Jiglaire C; Gentet JC; Jouve JL; Rochwerger A; Mattei JC; Bouvard D; Salas S
Oncotarget; 2016 Oct; 7(40):64702-64710. PubMed ID: 27608849
[TBL] [Abstract][Full Text] [Related]
19. CD146 expression in human breast cancer cell lines induces phenotypic and functional changes observed in Epithelial to Mesenchymal Transition.
Imbert AM; Garulli C; Choquet E; Koubi M; Aurrand-Lions M; Chabannon C
PLoS One; 2012; 7(8):e43752. PubMed ID: 22952755
[TBL] [Abstract][Full Text] [Related]
20. MUC1-C Represses the Crumbs Complex Polarity Factor CRB3 and Downregulates the Hippo Pathway.
Alam M; Bouillez A; Tagde A; Ahmad R; Rajabi H; Maeda T; Hiraki M; Suzuki Y; Kufe D
Mol Cancer Res; 2016 Dec; 14(12):1266-1276. PubMed ID: 27658423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
